The company operates as a non-banking financial institution primarily engaged in providing loans, credit facilities, and trading in equity shares and other financial instruments.
The company lacks any identifiable competitive advantage, as evidenced by its negative revenue growth and extremely thin net margins of 1.0%. Its operations are indistinguishable from a commodity money-lending business, and its ROCE of 10.3% barely covers the cost of capital.
Management has primarily deployed capital into inter-corporate deposits and equity trading, which have yielded poor returns as seen in the 1.9% ROE. There is a heavy reliance on related-party loans and borrowings rather than organic cash flow generation to fund the balance sheet.
The business likely collapsed as the shrinking revenue base, which had already been declining at double-digit rates, finally failed to cover the interest on its massive debt load. The reliance on related-party loans and inter-corporate deposits probably turned into a liquidity trap when those counterparties faced their own credit crunches, leaving the company with unrecoverable assets. As administrative costs remained high relative to the dwindling scale, the razor-thin 1% margins turned negative, and the lack of internal financial controls likely masked a terminal erosion of the capital base until it was too late for recovery.
RichFakir rates Abhinav Leasing & Finance Ltd's business quality as poor — 12/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Abhinav Leasing & Finance Ltd is trading about 54% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Abhinav Leasing & Finance Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Abhinav Leasing & Finance Ltd's fair value is about ₹1 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →